Youdao Filed 2024 Annual Report on Form 20-F

2025-04-17 IDOPRESS

HANGZHOU,China,April 15,2025 -- Youdao,Inc. ("Youdao" or the "Company") (NYSE: DAO),an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals,today announced that the Company had filed its annual report on Form 20-F for the full year ended December 31,2024with the U.S. Securities and Exchange Commission.

The annual report is available on the Company's investor relations website at ir.youdao.comand on the SEC's website at www.sec.gov. The Company will provide hard copies of the annual report,free of charge,to its shareholders and ADS holders upon written request. Requests should be directed to Investor Relations,Youdao,Inc.,No. 399 Wangshang Road,Binjiang District,Hangzhou 310051,People's Republic of China.

About Youdao,Inc.

Youdao,Inc. (NYSE: DAO) is strategically positioned as an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals. Youdao now mainly offers learning services,online marketing services and smart devices – all powered by cutting-edge technologies. Youdao was founded in 2006 as part of NetEase,Inc. (NASDAQ: NTES; HKEX: 9999),a leading internet technology company in China.

For more information,please visit: http://ir.youdao.com.

For investor and media inquiries,please contact:

In China:


Jeffrey Wang


Youdao,Inc.


Tel: +86-10-8255-8163 ext. 89980


E-mail: IR@rd.netease.com

Piacente Financial Communications


Helen Wu


Tel: +86-10-6508-0677


E-mail: youdao@thepiacentegroup.com

In the United States:


Piacente Financial Communications


Brandi Piacente


Tel: +1-212-481-2050


E-mail: youdao@thepiacentegroup.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

2The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

6MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

©copyright 2009-2020 Singapore Info Map